A new United States patent was just issued that is associated with IBS, otherwise known as irritable bowel syndrome.  The patent is for a dietary supplement called Lactospore that was invented by the supplement guru Dr. Muhammed Majeed.

From the website Nutracueticals World

“Patent No. US9579352 claims a method for managing the symptoms associated with IBS including abdominal pain, bloating or visible distension of abdomen, constipation and loose stools, by orally administering a formulation comprising Bacillus coagulans MTCC 5856 (not less than 2 billion spores) as a dietary supplement along with regular treatment. “

LactoSpore ameliorates the symptoms of IBS as seen in a recently published human clinical trial (Majeed et al. Nutrition Journal (2016) 15:21 DOI 10.1186/s12937-016-0140-6). In the study, LactoSpore demonstrated efficacy in relieving clinical symptoms in IBS patients.

In addition to the US patent, Health Canada, the Canadian version of the FDA, is allowing Lactospore to make the claim that Lactospore helps relieve abdominal pain associated with IBS.

If you are looking to use Lactospore it is available to purchase from AFI supplements